Maridi An Aerts

Dr. Maridi An Aerts

Uz-Brussel
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Radiology
Verified
Journal Article
Closed access
EDElisabeth Dhondt
Elisabeth Dhondt
BLBieke Lambert
Bieke Lambert
LHLaurens Hermie
Laurens Hermie
LHLynn Huyck
Lynn Huyck
PVPeter Vanlangenhove
Peter Vanlangenhove
LDLuc Defreyne
Luc Defreyne
Yttrium 90 radioembolization was superior to chemoembolization using drug-eluting beads for tumor control and survival in nonsurgical Barcelona Clinic Liver Cancer stage A and B hepatocellular carc... Background Transarterial chemoembolization (TACE) is the recommended treatment for intermediate hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver Cancer guidelines. Prospective...

23 May 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MAMaridi An Aerts
Maridi An Aerts
ZRZenzi Rosseel
Zenzi Rosseel
EWElisabeth De Waele
Elisabeth De Waele
The prevalence and incidence of NAFLD is rising due to the obesity pandemic, caused by the widespread availability of ultra-processed foods and the decrease of physical activity. Factors such as socioeconomic status (SES), ethnicity and geographical location are associated with NAFLD, with lower SES correlating with higher incidence, particularly in regions like America or Europe. Beside the quality of food, the quantity also plays a crucial role. The World Health Organization (WHO) recommends a Mediterranean diet with a balanced energy intake. Since no hard medical treatment is available for NAFLD, lifestyle adjustments are key. Patient empowerment by providing relevant information and co-ownership of the therapy will increase the implementation rate and enhance the quality of medical follow-up and medication adherence, as studies report a good adherence to medication among patients who are well-aware of the severity of their disease. Regarding sustainability, patients with NAFLD have a high load of ambulatory follow-up, which, since the COVID-19 pandemic, can be partially provided by teleconsulting. Both patients’ lifestyle modifications and healthcare practitioners’ therapeutical strategy can decrease the carbon footprint.

31 March 2020 in Caraka Tani: Journal of Sustainable Agriculture
Verified
Journal Article
Open access
PDF file
ISImah Solikhatun
Imah Solikhatun
MAMaridi An Aerts
Maridi An Aerts
MBMaria Theresia Sri Budiastuti
Maria Theresia Sri Budiastuti
Land conversion has caused the function of the greenbelt for reservoir to be less effective. The management of the greenbelt area is needed to maintain the primary function of the reservoir. Therefore, a vegetation analysis in the greenbelt area is necessary to evaluate the condition of the existing vegetation and community attitude to maintain the greenbelt area. This study aims at identifying the current condition of the greenbelt area and the diversity of vegetation as well as the community attitude at the greenbelt area of multipurpose reservoir of Wonogiri. Vegetation sampling was done by purposive sampling using directed line quadrant method, while community attitude sampling was performed using in-depth interviews. This study found 14 species of vegetation in the greenbelt area. The most significant contribution of vegetation species was shown by the Importance Value Index (IVI), with 14 species of tree in which teak (Tectona grandis L.) was the species with the highest IVI value. The species diversity index was 1.15-1.7 and it was included in the medium category. Reforestation efforts can be continued because the vegetation condition has shown moderate stability. Community attitudes towards the greenbelt largely support the existence of management although people still and will use the land without disturbing the existing plants. The reforestation program that has been carried out in the last few years is expected to be able to restore the greenbelt in support of the reservoir function.

27 October 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Rani L. KronenbergerRani L. Kronenberger
Rani L. Kronenberger
ILInes Van Loo
Ines Van Loo
Carlo de AsmundisCarlo de Asmundis
Carlo de Asmundis
MAMaridi An Aerts
Maridi An Aerts
SGSandro Gelsomino
Sandro Gelsomino
MMMark La Meir
Mark La Meir
Purpose The development of an atrio-esophageal fistula, a rare yet potentially lethal complication of ablation for atrial fibrillation, could be related to direct tissue heat transfer during and immediately after the ablation. We therefore studied the postoperative esophageal findings by esophagogastroduodenoscopy in patients that underwent a hybrid ablation procedure using a novel preventive strategy to avoid thermal lesions. Methods Thirty-four patients (28 males; 65 years ± 9 years) were retrospectively included. All underwent a hybrid ablation in our center between April 2015 and November 2019 and agreed to an esophagogastroduodenoscopy within 0–14 days (mean: 5 days) following the ablation. To reduce the incidence of thermal lesions three procedural preventive strategies were introduced: (i) videoscopic intrathoracic transesophageal echocardiographic probe visualization to understand the relationship between posterior left atrial wall and esophagus, with probe retraction before ablation; (ii) lifting the cardiac tissue away from the esophagus during energy application; and (iii) a 30-s cool-off period after energy delivery with irrigation of the device, the ablated tissue, and the surrounding tissues. Results No esophageal thermal lesions were observed. One third of patients were diagnosed with incidental esophageal findings unrelated to the ablation procedure (11; 32.4%). Conclusion Novel preventive strategies by visualization and by avoiding contact between the ablation catheter or ablated tissue and the pericardium, seems to eliminate the potential risk of esophageal thermal lesions in the setting of hybrid ablation. Since one third of patients had preexisting esophageal disease, a more comprehensive pre-operative screening could be important to reduce the risk.

1 March 2024 in Acta Gastro Enterologica Belgica
Verified
Journal Article
Closed access
MAMaridi An Aerts
Maridi An Aerts
HRH Reynaert
H Reynaert
PRP Roelandt
P Roelandt
PCP Caenepeel
P Caenepeel
PDP Dewint
P Dewint
ICI Colle
I Colle
The importance to reach the target to be carbon net zero by 2050, as presented by the European Commission in the European Green Deal, cannot be overestimated. In a current endoscopy world, where single use has found its place and techniques are constantly evolving, it will be a challenge to reach these goals. How can we reconcile this evolution to a carbon neutral status by 2050 without compromising patients care, clinical standards and training needs? The European Society of Gastrointestinal Endoscopy (ESGE) together with the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) recently published a position statement (1) whereas in the UK there is the work from the green endoscopy group (2) in line with the strategy of the British Society of Gastroenterology (BSG) on sustainability (3). In Flanders, a project called "greendeal in duurzame zorg" had its kick off in March 2023 (4) so it is about time that we in Belgium, as gastroenterologists, start with tangible actions to a more sustainable daily practice. We wrote this position statement in cooperation with the Vlaamse Vereniging voor Gastro-Enterologie (VVGE), the Soci & eacute;t & eacute; royale belge de Gastro-ent & eacute;rologie (SRBGE) and the Belgian Society of Gastrointestinal Endoscopy (BSGIE). We will also work together in the coming years to continue to motivate our members to work on these initiatives and to co-opt new projects within the framework of the greendeal. (Acta gastroenterol. belg., 2024, 87, 28-33). ).

6 December 2017 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
MAMaridi An Aerts
Maridi An Aerts
HRHendrik Reynaert
Hendrik Reynaert
Gastrinomas are functionally active pancreatic neuroendocrine tumors (NETs) secreting gastrin and are associated with local or regional metastases in 60% of the cases. Somatostatin analogs (SSAs) are currently recommended as a first-line treatment for the symptomatic treatment of NETs. Although antiproliferative activity of SSAs has been demonstrated in various cancer types in several in vivo and in vitro studies, clinical benefits with SSAs have been only achieved in a small proportion of patients. We report a disease control on a long-acting SSA lanreotide in a patient with metastatic gastrinoma. A 60-year-old man, who had previously undergone a surgical resection of metastatic pancreatic gastrinoma, presented with abdominal bloating, edema in the lower limbs, fatigue, and weight loss. The gastrinoma relapse with additional metastases in the pancreas, duodenum, and liver was confirmed by positron emission tomography-computed tomography (PET-CT) scan; the patient’s blood gastrin level was >5,000 ng/L. Treatment with the SSA octreotide long-acting release was initiated to treat the gastrinoma relapse. On the CT scan done in September 2011, the liver metastases were still identifiable. In December 2011, the treatment was switched to lanreotide Autogel® (120 mg every 2 weeks). Following the treatment, the gastrin levels were reduced to <1,200 ng/L in September 2013, and 812 ng/L in July 2016. Since November 2012, the gastrinoma lesions were no longer visible in abdominal CT. At the time of this report, the patient’s gastrinoma was under control with lanreotide Autogel®. This case report supports the use of lanreotide Autogel® as effective treatment for metastatic gastrinoma.